Compare ZLAB & AIRJW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | AIRJW |
|---|---|---|
| Founded | 2013 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | N/A |
| IPO Year | 2017 | 2021 |
| Metric | ZLAB | AIRJW |
|---|---|---|
| Price | $26.49 | $0.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $49.60 | N/A |
| AVG Volume (30 Days) | ★ 781.7K | 7.8K |
| Earning Date | 05-07-2026 | 03-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $26.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $0.46 |
| 52 Week High | $34.72 | $1.87 |
| Indicator | ZLAB | AIRJW |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 39.18 |
| Support Level | $16.84 | $0.98 |
| Resistance Level | $27.22 | $1.07 |
| Average True Range (ATR) | 0.88 | 0.05 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 80.44 | 14.71 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
AirJoule Technologies Corp is an advance technology company whose purpose is to free the world from its water and energy constraints by delivering groundbreaking sorption technologies. The company platform technology, AirJoule, produces pure distilled water from air and, at commercial scale, will mitigate water scarcity through distributed water generation for businesses and consumers around the world. Its products are especially valuable for industrial users, which generate amounts of waste heat that can be used to power sorption technologies to produce low-cost pure distilled water and dehumidified air, two key inputs for a variety of industrial activities, including data centers and advance manufacturing. The Company operates as a single operating and reportable segment.